Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -609.18% is 252% below its 1-year average of -173.22%, near the low end of its 1-year range (-700.35%–0.00%).
251.68% below its 12-month average of -173.22%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-609.18%
OPERATING MARGIN AVG TTM
-173.22%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-251.68%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 786 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pyxis Oncology, Inc.
Market Cap
$131.78M
Operating Margin
-609.18%
TTM Avg
-173.22%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$133.38M
Operating Margin
-11.60%
TTM Avg
-17.18%
3Y Avg
-31.98%
5Y Avg
-39.70%
Market Cap
$133.72M
Operating Margin
-9.35%
TTM Avg
-5.78%
3Y Avg
-14.39%
5Y Avg
-45.18%
Market Cap
$134.44M
Operating Margin
-34.07%
TTM Avg
-27.91%
3Y Avg
-72.83%
5Y Avg
-67.42%
Market Cap
$135.80M
Operating Margin
-7.85%
TTM Avg
-2.10%
3Y Avg
-0.51%
5Y Avg
4.29%
Market Cap
$136.16M
Operating Margin
-410.23%
TTM Avg
-412.58%
3Y Avg
-412.58%
5Y Avg
-412.58%
Market Cap
$126.92M
Operating Margin
-27450.00%
TTM Avg
-16372.79%
3Y Avg
-10624.45%
5Y Avg
-7949.52%
Market Cap
$137.30M
Operating Margin
-3.66%
TTM Avg
-13.20%
3Y Avg
-25.26%
5Y Avg
-22.69%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $131.78M | -609.18% | -173.22% | 0.00% | 0.00% |
| Health Catalyst, Inc. (HCAT)vs › | $133.38M | -11.60% | -17.18% | -31.98% | -39.70% |
| LifeMD, Inc. (LFMD)vs › | $133.72M | -9.35% | -5.78% | -14.39% | -45.18% |
| Organigram Global Inc. (OGI)vs › | $134.44M | -34.07% | -27.91% | -72.83% | -67.42% |
| Freenome, Inc. (FRNM)vs › | $135.49M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $135.80M | -7.85% | -2.10% | -0.51% | 4.29% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.16M | -410.23% | -412.58% | -412.58% | -412.58% |
| Entera Bio Ltd. (ENTX)vs › | $126.92M | -27450.00% | -16372.79% | -10624.45% | -7949.52% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.30M | -3.66% | -13.20% | -25.26% | -22.69% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $125.63M | -1324.41% | -662.21% | -331.10% | -220.74% |
Gross Margin
82.8%
Operating Margin
-609.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -165.75% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -700.35% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -34.71% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
